UBS has upgraded Watches of Switzerland Group PLC from 'neutral' to 'buy', driven by accelerating demand for luxury watches in the US, which has become the group's largest market. The bank raised its price target to 850p from 600p, implying a 16% upside. UBS highlights strong sales of Rolex and other high-end brands like Cartier, forecasting 10% sales growth for the year to April 2027, above company and market expectations. The firm also notes the company's insulation from the luxury slowdown due to limited China exposure and high average selling prices, while pointing to potential acquisitions in the fragmented US market. Risks include a US luxury slowdown, market correction, and Rolex brand fatigue.
A regional nonprofit health plan reduced its Transparency in Coverage machine-readable file (MRF) production time from 45 days to less than 24 hours by integrating TALON's platform directly with its claims administration system. This eliminated a com...
ASUS has introduced two new Chromebooks in the US market: the budget-friendly CM15 laptop and the versatile CM32 Detachable 2-in-1 device. Both run on the MediaTek Kompanio 540 processor, offer up to 12 hours of battery life, and feature military-gra...
Slate Medicines, a biotech firm focused on migraine treatments, has appointed Mark W. Hahn to its Board of Directors. Hahn brings over 25 years of experience in life sciences, including leading companies through financial milestones and FDA approvals...
The global clinical trials market is projected to grow from $135.51 billion in 2026 to $176.32 billion by 2030, at a CAGR of 6.8%. Growth is fueled by advances in AI-enabled trial design, decentralized and hybrid trial platforms, and increasing deman...
The global hybrid robots market is projected to grow from $5.68 billion in 2026 to $10.03 billion by 2030, with a CAGR of 15.3%. Growth is fueled by advances in AI, autonomous operations, and smart manufacturing, alongside rising demand for robots in...
